Clinical Trials List
2020-04-01 - 2025-01-31
Phase I
Terminated5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳振德 Division of Radiology
- 邱立忠 Division of Thoracic Medicine
- Chih-Hung Chen Division of General Internal Medicine
- 吳教恩 Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
- Chih-Liang Wang Division of General Internal Medicine
- 林定佑 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jui-Hung Tsai Division of Hematology & Oncology
- Chien-Chung Lin Division of Thoracic Medicine
- Wu-Chou Su Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
- Po-Lan Su Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林正耀 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 蔡子修 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- 徐偉勛 Division of Hematology & Oncology
- 廖唯昱 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- JIN-YUAN SHIH Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chang-Fang Chiu Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
65 participants
